Overcoming Challenges and Managing Risks in Pharmaceutical M&A
Olha O. Demianiuk
The healthcare sector was the most dominant industry in global M&A in 2014. In fact, 2014 was a record-breaking year for M&A in the healthcare sector, with deal values reaching USD 363 billion, 94% higher than those in 2013. Of those deals, almost 50% were cross-border transactions in which buyers acquired target companies or assets in countries outside their local markets.
The abstract/extract view of this article is free. Access to the full text of this article requires a subscription.
Please send subscription inquiries by:
Phone: +380 44 495-27-27
E-mail: subscribe@ujbl.info